Grail, Inc. (NASDAQ:GRAL) Short Interest Update

by · The Cerbat Gem

Grail, Inc. (NASDAQ:GRAL – Get Free Report) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 4,900,000 shares, an increase of 11.9% from the November 30th total of 4,380,000 shares. Based on an average trading volume of 800,300 shares, the days-to-cover ratio is presently 6.1 days. Currently, 17.0% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on GRAL. Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock. Finally, Guggenheim started coverage on shares of Grail in a research note on Thursday, October 17th. They set a “neutral” rating for the company.

View Our Latest Stock Analysis on GRAL

Insiders Place Their Bets

In related news, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. This represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 123,454 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the completion of the sale, the chief executive officer now directly owns 612,661 shares in the company, valued at approximately $8,589,507.22. This represents a 16.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have bought a total of 58,829 shares of company stock valued at $757,298 in the last quarter.

Grail Trading Down 3.5 %

Shares of GRAL stock traded down $0.69 during mid-day trading on Monday, hitting $18.91. The stock had a trading volume of 405,438 shares, compared to its average volume of 1,078,906. Grail has a 12-month low of $12.33 and a 12-month high of $24.92. The stock has a 50-day moving average of $17.02.

Grail Company Profile

(Get Free Report)

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.

Featured Articles